fbpx

Blog

ACT pharmacists recognised with Excellence Awards

10 February 2024

 

The Pharmaceutical Society of Australia (PSA) has recognised the Australian Capital Territory’s top pharmacists as part of the 2024 PSA Excellence Awards tonight in Canberra.

The ACT Pharmacist of the Year is Kirstin Turner MPS

Canberra pharmacist Kirstin Turner is a Credentialed Pharmacist and Credentialed Diabetes Educator practising in both General and private practice in the ACT. Working with patients of all types of diabetes diagnoses, Kirstin specialises in medication optimisation for elderly patients experiencing diabetes related complications.

On top of maintaining her practice workload, Ms Turner continues to give back to the profession by mentoring and sharing more than a decade of clinical practice experience with recently credentialed pharmacists. Ms Turner’s commitment to sharing her accumulated wealth of experience with pharmacists, the multidisciplinary team, and patients that really stands out.

Ms Turner’s sustained and unwavering focus on the quality use of medicines and medicine safety, both as part of the multidisciplinary health care team and as a distinct health practitioner, exemplifies a true commitment to the pharmacy profession and the wider Canberra community.

The joint ACT Early Career Pharmacists of the Year are Alicia Martin MPS and Jaqueline Lockley MPS

Alicia Martin is a community pharmacist in Canberra’s south and is the founder of TaperMate, a mobile app to help patients safely taper their use of medications that cause withdrawal symptoms, particularly in the mental health space. TaperMate was born from Alicia’s clinical knowledge and passion for harm minimisation and improving consumer health literacy, working to bridge the gap between prescribers and consumers by centralising pharmacist advice and supporting true patient-centred care.

Ms Martin is involved in the Canberra Innovation Network and received YWCA Canberra’s Great Ydeas Grant in 2023 to support the development of TaperMate.

Through both TaperMate and her community pharmacy practice, Ms Martin demonstrates very strong professional leadership and an unwavering commitment to improving the use of mental health medicines and consumer health literacy more broadly.

Jacqueline Lockley is a community pharmacist in Canberra’s inner north, utilising pharmacogenomic testing to support specialised patient care. Ms Lockley promotes the use of pharmacogenomic testing to a range of health professionals, including psychologists and psychiatrists, mental health nurses and general practitioners, aiming to reduce medication misadventure, and improve quality use of medicines by optimising therapy based on an individual’s genetic profile.

Ms Lockley volunteers with the Salvation Army in Braddon, providing free advice and services to Canberrans doing it tough. She provides these services without judgement in a safe, familiar environment, supporting members of the community experiencing substance abuse disorders who may not feel comfortable accessing care in a traditional community pharmacy setting.

Ms Lockley established Self-Harmers Anonymous Australia, a 12-step program to support individuals struggling with self-harm around the country. She also provides information and resources to the friends and families affected by self-harm, supporting them to respond with empathy and understanding.

Ms Lockley is also a pharmacist representation on the ACT’s Capital Health Network Advisory Council, working to improve access and the delivery of quality healthcare to all Canberrans.

 

The ACT Lifetime Achievement Award is presented to Amanda Galbraith MPS

As the ACT’s Acting Chief Pharmacist, Amanda Galbraith has lead work to develop pharmacists’ scope of practice through the expansion of pharmacist administered vaccines and the opportunity for Canberra pharmacies to supply treatment for urinary tract infections, improving access to care for Canberra women.

Ms Galbraith has held a number of leadership positions across the pharmacy sector, including as President of the Pharmacy Guild of Australia (ACT Branch), a Pharmaceutical Defence Limited Director, and presently as Chair of the Australian Pharmacy Council’s FARM Committee.

Ms Galbraith’s passion for helping those around her extends to her work with the Pharmacists’ Support Service, offering support related to the many demands of being a pharmacist in Australia. Throughout her career, she has worked to promote First Nations Health, and importantly to promote the careers of First Nations pharmacists. Ms Galbraith is an asset to the ACT health system and the pharmacy profession more broadly.

 

On behalf of PSA, ACT President Olivia Collenette MPS congratulates the pharmacists recognised in this evening’s reception.

“Canberra pharmacists are embodying what it means to be a pharmacist, providing patient-centred care through innovation, excellence in practise, and commitment to our profession.

“A special congratulations to Kirstin, Alicia, Jacqueline and Amanda on your contributions not only to the pharmacy profession, but to the health of all Canberrans.”

Media contact:   Georgia Clarke   M: 0480 099 798  E: georgia.clarke@psa.org.au

SA expands pharmacy services to UTI treatment, 24/7 pharmacy opens

6 February 2024

 

The Pharmaceutical Society of Australia (PSA) welcomes the opening of the first 24/7 community pharmacy in Adelaide over the weekend by SA Health Minister Chris Picton.

At the opening, Minister Picton also announced that pharmacists who undergo additional training will be able to supply treatment for uncomplicated Urinary Tract Infections (UTIs) from March 2024.

PSA South Australia and Northern Territory President Dr Manya Angley FPS said that the round-the-clock access to medicines and health advice – including treatment for uncomfortable UTIs – gives consumers confidence in accessibility to health care.

“With support from the State Government, consumers in Adelaide now have 24-hour access to pharmacists, providing peace of mind that if they get sick or need after hours health advice, they will be able to access expert care from a trusted health professional,” Dr Angley said.

“Health care needs can change unpredictably at all hours of the day or night. People who require medicines for pain management or other palliative care medicines can be assured they can access them around-the-clock, along with the advice and expertise of pharmacists ready to help.

“Pharmacists are critical to improving the accessibility of care and reducing unnecessary stress on our hospital systems, helping to triage, manage and consult on acute common ailments like uncomplicated UTIs.

“Giving consumers an option for acute care outside of visiting an emergency department is key, especially out of hours where there are fewer options for care.

“PSA is looking forward to continuing our work with the South Australian Government and Minister Picton to further improve access to quality healthcare, utilising South Australia’s excellent pharmacists.”

PSA’s Managing uncomplicated cystitis training program is now available to all South Australian pharmacists. Successful completion allows the pharmacist to provide an assessment and treatment, if deemed appropriate, for uncomplicated UTIs in women aged 18 to 65, once the program commences in March 2024.

National Pharmacies in Norwood, South Australia is now open 24 hours a day, seven days a week. Chemist Warehouse at the Saints Shopping Centre in Salisbury Plain and Chemist Warehouse at Clovelly Park will begin operating 24/7 in coming weeks.

 

 

Media contact:   Georgia Clarke   M: 0480 099 798  E: georgia.clarke@psa.org.au

APF26 supporting developing practice

6 February 2024

 

The Pharmaceutical Society of Australia (PSA) is set to release the 26th print edition of the Australian Pharmaceutical Formulary (APF) later this month, featuring updated guidance and information on a range of clinical topics.

With the publishing of APF26, pharmacists have access to a fully revised section on Compounding, an updated Treatment Guidelines for Pharmacists section, and updated Cautionary Advisory Label (CAL) recommendations.

PSA National President Associate Professor Fei Sim FPS said each edition of the APF reflects updated expected practices, supporting quality pharmacy practice across roles and settings.

“As our practice evolves to meet the future health needs of Australians, so does the APF,” A/Prof Sim said.

“APF supports the role of pharmacists in achieving medicine safety backed by evidence-based information at all stages of the medication management cycle, including dispensing, compounding, therapeutic management, and providing health information.

“Whether practicing in community, hospital, embedded and consultant pharmacy roles, using the APF as clinical decision support at the point of care continues to promote the safe and effective use of medicines,” A/Prof Sim concluded.

APF26 contains the most important update to the Compounding section seen for many editions. Key changes in the section include:

  • detailed guidance on assigning expiry dates to compounded medicines (including sterile medicines)
  • clear explanation of the legislative and regulatory framework that applies to compounding
  • expanded guidance on compounding sterile medicines and handling or compounding hazardous medicines
  • new guidance about manipulating and repackaging commercial products
  • new guidance about water used for compounding medicines or for manipulating commercial products into a ready-to-administer form.

Pharmacists who are involved with the following clinical activities will find guidance in APF that is relevant to their practice:

  • simple or complex compounding
  • handling or compounding hazardous medicines
  • repackaging medicines (e.g. into a dose administration aid)
  • manipulating commercial products into a ready-to-administer form (e.g. reconstituting antibiotics)

The Treatment Guidelines for Pharmacists section has been expanded and includes 30 health conditions. The new Treatment Guidelines include:

  • anorectal disorders
  • cold sores
  • conjunctivitis
  • weight management.

Each Treatment Guideline has been written to help pharmacists easily find the key information they need at the point of care.

The Pharmacy Board of Australia requires all pharmacists to have ready access to APF during clinical assessment and reviewing, dispensing, and counselling processes. APF digital subscribers will automatically have access to all new and updated APF26 content.

Pre-orders for the print edition of APF26 are open now. Visit https://www.psa.org.au/media-publications/australian-pharmaceutical-formulary/

Media contact:   Georgia Clarke   M: 0480 099 798  E: georgia.clarke@psa.org.au

The Pharmaceutical Society of Australia is the only national peak body that represents all of Australia’s pharmacists across all practice settings. We want every Australian to have access to the best healthcare, and this must include optimising access to pharmacists’ knowledge and medicines expertise at the forefront of our healthcare system.

2024-25 Federal Budget submission: Building a healthcare system for the future

5 February 2024

 

The Pharmaceutical Society of Australia (PSA) is calling for investment into pharmacy and pharmacist services to improve access and equity of care as part of its 2024-25 Federal Budget Submission.

As the peak professional body for pharmacists in all areas of practice, PSA calls for the upcoming Federal Budget to support patients’ access to care and medicines through funded community pharmacist-led consultation services, an expanded National Immunisation Program Vaccinations in Pharmacy program, support for participation in multidisciplinary case conferencing, and nation-wide mental health first aid training.

Importantly, PSA also calls for the permanent introduction and funding of the Integrating Pharmacists within Aboriginal Community Controlled Health Services to Improve Chronic Disease Management, or IPAC Project, embedding vital medicines safety advocacy into Aboriginal and Torres Strait Islander primary health services. The IPAC Project is critically supported by the National Aboriginal Community Controlled Health Organisation (NACCHO) and the Medical Services Advisory Committee (MSAC).

PSA’s recommendations signal the impact that increased scope for pharmacist services can have on the broader health system.

PSA National President Associate Professor Fei Sim FPS says that funding for pharmacist services is key to equitable and accessible care now and into the future.

“This year’s Budget is an opportunity to strengthen our healthcare system, ensuring that its fit for purpose and able to meet the current and future health needs of our population,” A/Prof Sim said.

“Pharmacists should be supported to deliver more vaccinations, to act as a key consultation and triage point, and to offer crisis support to people experiencing mental ill health.

“Pharmacists should be funded to continue our vital role in Aboriginal and Torres Strait Islander primary health services as part of the IPAC program supported by the National Aboriginal Community Controlled Health Organisation and the Medical Services Advisory Committee.

“These recommendations bolster medicine safety, and recognise pharmacists’ roles in disease management, and support access to care for all Australians.

“We can make a real difference to the patients we serve, and the health system more broadly, but our pharmacy workforce should be supported to be in these roles.

“PSA is calling for investment across five key areas that support patient access to care, bolster the quality use of medicines and medicines safety, and recognise our roles as critical to improving the disease management.

“Investing in community-based care and quality use of medicines is investing in accessible and equitable care for Australians when and where they need it,” A/Prof Sim concluded.

PSA’s full Budget Submission is available at https://www.psa.org.au/advocacy/budget-submissions/

Media contact:   Georgia Clarke   M: 0480 099 798  E: georgia.clarke@psa.org.au

Vaccination funding should be consistent: Sim

31 January 2024

 

The Pharmaceutical Society of Australia (PSA) welcomes news that payments for pharmacist administration of COVID-19 vaccinations will be increased from tomorrow (1 February 2024) but urges similar increases across the National Immunisation Program Vaccinations in Pharmacy program.

 

The Pharmacy Programs Administrator (PPA) has confirmed that the new fee for COVID-19 Vaccine Administration Payments for all doses will be raised to $30.65. The Vaccination Incentive – Site Visit fee will not increase.

PSA National President A/Prof Fei Sim FPS said that increases should also apply to payments for NIPVIP vaccines.

“While I welcome increases in pharmacist remuneration for administering vital COVID-19 vaccines, it further highlights the growing inequality in funding for other vaccines delivered by pharmacists,” A/Prof Sim said.

“This change recognises the costs involved in delivering vaccination services, and it should be applied to all vaccines expected to be delivered by pharmacists. All vaccination services, regardless of whether under the COVID-19 Vaccination in Community Pharmacy Program or the National Immunisation Program Vaccinations in Pharmacy program, should be remunerated at the same rate.

This should include commitment to indexing of fees to keep pace with CPI, inclusion of rural loading, after hours incentives and incentives for reaching at risk and priority populations. The NIPVIP program should also support outreach services so pharmacists can support people wherever they live, including in aged care and disability facilities

“Adequate pharmacist remuneration is critical to ensuring that these essential services delivered by pharmacists can be delivered sustainably, which ultimately protects and maintains equitable access to vaccination services for all Australians.”

Media contact:   Georgia Clarke   M: 0480 099 798  E: georgia.clarke@psa.org.au

Unleashing the potential of pharmacists: Scope of practice review

31 January 2024

 

The Pharmaceutical Society of Australia (PSA) welcomes the release of the first issue paper from the Unleashing the Potential of our Health Workforce Scope of Practice Review (the Cormack Review) last week.

The issues paper recognises the existing barriers that are preventing Australia’s healthcare professionals, including pharmacists, from practising to their full and top of scope.

PSA National President A/Prof Fei Sim FPS said that the paper highlights both the urgent and the long-term need for pharmacists to contribute to improving access to care and medicine safety through working to their full and top of scope.

“The Cormack Review’s first issues paper confirms that inconsistent regulations, unnecessary restrictions on practice, and siloed workforces are having a detrimental impact on patients,” A/Prof Sim said.

“As pharmacists, we welcome the paper as the first step in the review process, however we need to now look towards solutions.

“PSA is making the case for solutions that recognise the potential of pharmacists as vital members of the healthcare team.

“PSA sees a future where community pharmacies are supported and funded to fulfill their primary care role as urgent care clinics where pharmacists can triage, manage and consult on a range of acute common ailments.

“This includes the ability to prescribe PBS medicines, harnessing the accessibility of pharmacists to deliver timely, cost-effective care – dramatically reducing patients’ out-of-pocket costs.

“We see a future where pharmacists are embedded in multidisciplinary health care teams wherever medicines are prescribed, supplied, administered, or reviewed, and where pharmacists are utilised to support patients in managing chronic health conditions – whether that is a medicine or a referral to another healthcare provider.

“To achieve these aims, regulatory, financial and systems barriers must be recognised and removed, and only until then, we can see the full potential of pharmacists unleashed.

“As the next phase of consultation begins, we are continuing to advocate directly to government for the future of our profession and importantly, the future of our patients.”

A/Prof Fei Sim currently sits on the Cormack Review’s Expert Advisory Committee, representing the pharmacy profession.

Media contact:   Georgia Clarke   M: 0480 099 798  E: georgia.clarke@psa.org.au

Pharmacists recognised in Governor-General’s Honours

26 January 2024

 

On behalf of the pharmacy profession, the Pharmaceutical Society of Australia (PSA) acknowledges and congratulates the Australian pharmacists recognised in today’s Governor-General’s honours.

 

The following pharmacists received Honours from the Governor-General today:

  • ​Dr Jennifer (Jenny) Gowan FPS, Member of the Order of Australia (AM)
  • Mr Desmond Lum MPS, Medal of the Order of Australia (OAM)
  • Ms Julie Rose Adams, Medal of the Order of Australia (OAM)

 

PSA National President A/Prof Fei Sim FPS congratulated the award recipients.

“The pharmacists recognised today have dedicated their lives to the health of their communities,” Dr Sim said.

“Congratulations to Dr Jenny Gowan, Mr Demond Lum, and Ms Julie Adams on your outstanding careers and your recognition as pillars of the community.

“On behalf of Australians, thank you for your contributions to our profession and our country,” A/Prof Sim said.

Dr Jennifer (Jenny) Gowan FPS

Dr Jenny Gowan FPS is a widely celebrated credentialed pharmacist, having been awarded PSA’s 2013 Pharmacist of the Year award as well as the AACP’s Consultant Pharmacist of the Year award in 2016.

Dr Gowan served on PSA’s Victorian Branch Committee for many years, and as the Branch’s Vice-President from 2021 to 2023. She has been a member of the PSA for 48 years.

Dr Gowan has been recognised by the Governor-General for her significant service to medicine as a pharmacist, to professional societies, and to community health.

Mr Desmond Lum MPS

Former community pharmacist Desmond Lum MPS has been recognised for his service to the communities of Holbrook and Thurgoona. Following a 30-year career as a pharmacist, Mr Lum has continued giving back to his communities through the Thurgoona Lions Club, the Thurgoona Men’s Shed, St Patrick’s School and various other organisations in the Albury-Wodonga region.

Mr Lum is a life member of the PSA, having been a member for 53 years.

Ms Julie Adams

Hospital Pharmacist Julie Adams was recognised for her service to pharmaceutical oncology.

Ms Adams has become a leader in oncology pharmacy and has expanded the role of pharmacists through innovation, research, and education. Ms Adam’s passion for pharmacy throughout her career has resulted in her being an inspirational member of the profession and a worthy recipient of the Pharmaceutical Society of Western Australia’s 2020 Eric Kirk Memorial Award.

PSA also congratulates former staff member Mr Peter Waterman, who was awarded a Medal of the Order of Australia for his service to media and journalism.

Media contact:   Georgia Clarke   M: 0480 099 798  E: georgia.clarke@psa.org.au

Next generation learning for pharmacy assistants, interns

25 January 2024

 

The Pharmaceutical Society of Australia (PSA) has partnered with tech company Audirie to modernise pharmacy assistant and intern training programs, integrating tailored learning tools and real-time assessment into pharmacy education.

PSA learners will soon have access to virtual patients as part of their online learning environment, supporting the real-world application of their training material.

PSA Chief Executive Officer Adj A/Prof Steve Morris welcomed the new partnership, reaffirming the organisation’s commitment to enhanced education across the pharmacy sector.

“As a leader in pharmacy education and training, PSA’s excited to provide learners with new and innovative products as part of their education journey.

“We’re proud to be harnessing technology to give our learners the edge, training in real-life scenarios and better preparing them for their careers.

“Our focus remains firmly on providing high quality, practical education to our members and learners, training them to meet the current and future needs of our communities,” he said.

Audirie Chief Executive Officer Michael Alexander said the partnership represented a groundbreaking approach to education in the pharmacy sector.

“As a pharmacist myself, I am excited to collaborate with the Pharmaceutical Society of Australia and bring Audirie to the forefront of pharmacy education,” he said.

“This partnership is a significant step forward in integrating new technologies into the training and assessment processes, ultimately benefitting pharmacy professionals and the industry as a whole.”

About Audirie

Audirie is a leading provider of AI-driven communication solutions, committed to transforming the way individuals learn and grow. With a focus on immersive learning experiences, Audirie harnesses the power of artificial intelligence to deliver innovative and effective training programs across various industries.

Media contact:   Georgia Clarke   M: 0480 099 798  E: georgia.clarke@psa.org.au

Access to RSV vaccine critical to its efficacy

19 January 2024

 

Following the welcome approval of a new vaccine to protect older Australians against the highly infectious respiratory syncytial virus (RSV), the Pharmaceutical Society of Australia (PSA) is urging governments to ensure its accessibility for those most at risk.

This week the Therapeutic Goods Administration (TGA) approved AREXVY for Australians aged 60 and over, the first RSV vaccine approved in Australia.

PSA National President A/Prof Fei Sim FPS said that allowing pharmacists to administer the vaccine would significantly improve its uptake and in turn, reduce hospitalisations from severe infections.

“Having a vaccine on the market is not enough, we need to ensure that it’s as accessible as possible to those who need it most,” A/Prof Sim said.

“Pharmacist immunisers are limited by red-tape and regulation imposed by states and territories, preventing them from fulfilling their potential to administer all vaccines to all at-risk Australians.

“Millions of Australians attend pharmacies for their vaccinations, with more than 15 million COVID-19 and influenza vaccines administered by pharmacists over the last few years.

“By making vaccinations more accessible to vulnerable groups, we can limit the serious health complications RSV can cause and in turn reduce hospitalisations.

“Allowing pharmacists to practise to the top of their scope makes efficient use of health resources, benefitting the broader health system.

“I urge all state and territory governments to authorise pharmacists to provide the RSV vaccine, supporting access to preventive care and keeping older Australians healthy and well.

“This access should extend to all vaccines, for all eligible people, in all locations where pharmacists work.

“Reducing barriers to vaccination, reducing barriers to care, should always be our priority,” A/Prof Sim concluded.

AREXVY will soon be made available nationally, on private prescription.

Media contact:   Georgia Clarke   M: 0480 099 798  E: georgia.clarke@psa.org.au

Tasmanian pharmacists to support palliative care at home

18 January 2024

 

The Pharmaceutical Society of Australia (PSA) has partnered with the Tasmanian Government to help support palliative care patients stay at home and receive the care and medicines they need in a comfortable, familiar environment.

Announced by Health Minister Guy Barnett MP in Launceston today, the program supports community pharmacies across Tasmania to continuously stock essential palliative care medicines, ensuring these are available to patients across the state when needed.

PSA will deliver training in the provision of essential palliative care medicines for pharmacists and GPs as part of the program, ensuring the safe and quality use of medicines thanks to funding from the Tasmanian Department of Health.

PSA Tasmanian President David Peachey MPS said the joint approach demonstrated a commitment to improving palliative care for all Tasmanians.

“PSA is proud to be a part of this innovative program to improve services and support for palliative care patients within our community,” Mr Peachey said.

“Timely access to medicines to manage end of life symptoms is essential to a quality end of life journey for patients and their families. Palliative medications are needed within hours, not days, which is why it is so important that they are easily accessible within the community.

“Having more Tasmanian pharmacists educated and trained to supply palliative medicines means that we can make their safe and quality use more accessible to more people at the end of their lives,” Mr Peachey concluded.

PSA National President Dr Fei Sim FPS also welcomed the move, pointing to the growing role of pharmacists in palliative care following nation-wide consultation on the upcoming palliative care foundation training program.

“Upskilling local pharmacists in palliative care will increase the capacity of community palliative care teams, community pharmacists, and general practitioners to provide care to patients at the end of life,” she said.

“Pharmacists will increase collaboration and coordination of local palliative care services, reducing unnecessary hospital presentations.

“We look forward to evolving the support for pharmacists within the palliative care team as part of the ComPPaCT initiative,” Dr Sim concluded.

The pharmacist palliative care foundation training program will be available to all Australian registered pharmacists. More information and instruction on how to enrol will be communicated to PSA members in 2024.

Media contact:   Georgia Clarke   M: 0480 099 798  E: georgia.clarke@psa.org.au